10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomized FREEDOM trial and open-label extension - Bone, H G; Wagman, R B; Brandi, M L (Lancet Diabetes Endocrinol, 2017)
. doi:10.1016/S2213-8587(17)30138-9